Everyone from rock stars to nonagenarians experiences hearing loss, but no drugs have ever been approved specifically to prevent or treat this problem. Recently, a handful of drug companies have started to make some noise, with a number of experimental compounds now in human trials. Elie Dolgin sounds off on what could be a multibillion dollar market.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rauch, S.D. et al. J. Am. Med. Assoc. 305, 2071–2079 (2011).
Lin, F.R., Niparko, J.K. & Ferrucci, L. Arch. Intern. Med. 171, 1851–1852 (2011).
Suckfuell, M., Canis, M., Strieth, S., Scherer, H. & Haisch, A. Acta Otolaryngol. 127, 938–942 (2007).
Ewert, D.L. et al. Hear. Res. 285, 29–39 (2012).
Lynch, E. & Kil, J. Semin. Hear. 30, 47–55 (2009).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. Sound medicine. Nat Med 18, 642–644 (2012). https://doi.org/10.1038/nm0512-642
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0512-642
